scholarly journals Disulfide Bonds in the Ectodomain of Anthrax Toxin Receptor 2 Are Required for the Receptor-Bound Protective-Antigen Pore to Function

PLoS ONE ◽  
2010 ◽  
Vol 5 (5) ◽  
pp. e10553 ◽  
Author(s):  
Jianjun Sun ◽  
R. John Collier
2014 ◽  
Vol 210 (2) ◽  
pp. 154.e1-154.e8 ◽  
Author(s):  
Joy Yumiko Vink ◽  
Pelisa Cheryll Charles-Horvath ◽  
Jan Krzysztof Kitajewski ◽  
Claire Vech Reeves

PEDIATRICS ◽  
2006 ◽  
Vol 118 (5) ◽  
pp. e1485-e1492 ◽  
Author(s):  
J. T.C. Shieh ◽  
P. Swidler ◽  
J. A. Martignetti ◽  
M. C. M. Ramirez ◽  
I. Balboni ◽  
...  

2021 ◽  
Author(s):  
Shahan Mamoor

Breast cancer affects women at relatively high frequency (1). We mined published microarray datasets (2, 3) to determine in an unbiased fashion and at the systems level genes most differentially expressed in the primary tumors of patients with breast cancer. We report here significant differential expression of the gene encoding anthrax toxin receptor 2, ANTXR2, when comparing primary tumors of the breast to the tissue of origin, the normal breast. ANTXR2 mRNA was present at significantly lower quantities in tumors of the breast as compared to normal breast tissue. Analysis of human survival data revealed that expression of ANTXR2 in primary tumors of the breast was correlated with post-progression survival in patients with basal subtype cancer, demonstrating a relationship between primary tumor expression of a differentially expressed gene and patient survival outcomes influenced by molecular subtype. ANTXR2 may be of relevance to initiation, maintenance or progression of cancers of the female breast.


2012 ◽  
Author(s):  
Lorna Cryan ◽  
Kaiane A. Habeshian ◽  
Shugeng Cao ◽  
Jon Clardy ◽  
Kenneth Christensen ◽  
...  

2018 ◽  
Vol 115 (46) ◽  
pp. E10934-E10940 ◽  
Author(s):  
Nadishka Jayawardena ◽  
Laura N. Burga ◽  
Richard A. Easingwood ◽  
Yoshimasa Takizawa ◽  
Matthias Wolf ◽  
...  

Recently, the use of oncolytic viruses in cancer therapy has become a realistic therapeutic option. Seneca Valley Virus (SVV) is a newly discovered picornavirus, which has earned a significant reputation as a potent oncolytic agent. Anthrax toxin receptor 1 (ANTXR1), one of the cellular receptors for the protective antigen secreted by Bacillus anthracis, has been identified as the high-affinity cellular receptor for SVV. Here, we report the structure of the SVV-ANTXR1 complex determined by single-particle cryo-electron microscopy analysis at near-atomic resolution. This is an example of a shared receptor structure between a mammalian virus and a bacterial toxin. Our structure shows that ANTXR1 decorates the outer surface of the SVV capsid and interacts with the surface-exposed BC loop and loop II of VP1, “the puff” of VP2 and “the knob” of VP3. Comparison of the receptor-bound capsid structure with the native capsid structure reveals that receptor binding induces minor conformational changes in SVV capsid structure, suggesting the role of ANTXR1 as an attachment receptor. Furthermore, our results demonstrate that the capsid footprint on the receptor is not conserved in anthrax toxin receptor 2 (ANTXR2), thereby providing a molecular mechanism for explaining the exquisite selectivity of SVV for ANTXR1.


Sign in / Sign up

Export Citation Format

Share Document